Lucintel's latest market report analyzed that cell therapy technology provides attractive opportunities in biopharmaceutical and biotechnology companies, CROs & CMOs, and research institutes & cell banks. The cell therapy technology market is expected to reach $8.7 billion by 2028 with a CAGR of 14.5%. In this market, stem cell is the largest segment by cell type, whereas research institutes and cell bank is largest by end use industry.
Download Brochure of this report by clicking on https://www.lucintel.com/cell-therapy-technology-market.aspx
Based on cell type, the cell therapy technology market is segmented into T-cell, stem cell, and others. The stem cell segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to the increasing need for therapies for neurological diseases and growing awareness of stem cell storage.
Browse in-depth TOC on “Cell Therapy Technology Market”
100 – Figures/Tables
150 – Pages
The Cell Therapy Technology Market is marked by the presence of several big and small players. Some of the prominent players offering cell therapy technology include Pharmicell, Corestem, Chiesi Farmaceutici, Tego Science, and Anterogen.
Request Sample Report:
https://www.lucintel.com/cell-therapy-technology-market.aspx
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.